Clinical Trial Update: Allogeneic Hematopoietic Cell Transplantation for Disorders of T-cell Proliferation and/or Dysregulation [Phase 2]

View source ↗

Summary

A Phase 2 study evaluating allogeneic hematopoietic cell transplantation for disorders of T-cell proliferation and/or dysregulation, sponsored by the National C…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Autoimmune Lymphoproliferative Syndrome
• Common Variable Immunodeficiency
• Lymphoproliferative Disorders
• T-cell Immunodeficiency Disorders

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Lymphoproliferative Disorders, Autoimmune Lymphoproliferative | Phase 2 | Status: ACTIVE_NOT_RECRUITING | Results posted: 2026-03-17